SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the announcement of UAE marketing authorization for Anktiva, which investors view as a pivotal step in global expansion and a potential catalyst to squeeze heavily shorted positions. Community sentiment remains focused on anticipating further international partnership news and upcoming quarterly financial results, while many continue to express frustration over the stock's volatility and the perceived lack of timely transparency from leadership.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is fueling market optimism after reporting strong quarterly results highlighted by accelerated Azure cloud growth and resilient demand for AI services. The community is actively discussing the company's ability to maintain healthy margins while keeping capital expenditures in check, signaling a potential turnaround for the broader tech sector.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing intense volatility as investors react to a hawkish Federal Reserve stance and escalating geopolitical tensions, which have collectively triggered a sharp sell-off in the tech sector. The community is actively debating the sustainability of AI capital expenditures amid signs of a broader market correction and increased margin pressure.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing a sharp sell-off despite beating earnings expectations and raising guidance, as investors react to management's cautious outlook regarding potential interest rate hikes and broader market macro concerns. While bulls view the dip as an undervalued buying opportunity, the community remains deeply divided, with many debating whether the stock's persistent post-earnings weakness reflects fundamental concerns or artificial manipulation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood investors are closely watching the upcoming earnings report, with sentiment divided between enthusiasm for record-breaking product velocity and concerns over the stock's recent volatility. The community is actively debating the company's potential to scale into a trillion-dollar market cap while navigating broader market headwinds that have impacted recent price action.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors react to a notable earnings per share miss and concerns over aggressive capital expenditure guidance aimed at AI infrastructure. The community is sharply divided, with bears emphasizing the erosion of free cash flow and a lack of clear AI monetization, while bulls argue that the sell-off is an overreaction to transient one-time charges and that the company remains a dominant, undervalued advertising powerhouse.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is currently trending as investors debate its potential for a turnaround following strategic partnerships, such as the Walmart deal, and BetterHelp’s ongoing shift toward insurance-covered therapy. While some market participants express frustration over leadership and stock performance, others view the company as a deeply undervalued leader in digital health infrastructure and a potential target for a short squeeze given the high volume of short interest.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors weigh recent strategic leadership hires and government contract activity against broader market volatility impacting the quantum sector. The community is actively debating the stock's long-term valuation versus short-term price pressure, with many using recent dips as an opportunity to accumulate shares ahead of upcoming earnings.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is seeing significant volatility as investors digest a beat-and-raise quarterly earnings report alongside news that a former major beef supply restriction has been lifted. While community sentiment remains divided between those optimistic about the long-term growth strategy and skeptics concerned about valuation and traffic, the stock has been a focal point for intense after-hours trading and discussions regarding its competitive positioning.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in November 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinet shares are trending following a blowout Q2 earnings report where strong billings and an raised full-year outlook beat analyst expectations, driven by demand for AI-driven security and the FortiGate firewall series. The community is actively discussing the company's long-term potential as an infrastructure leader, with many noting the stock's significant momentum as it recovers from recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CMPS A high-risk, high-reward play on the future of mental health treatment. If its late-stage psilocybin therapy succeeds, the company could become a leader in treatment-resistant depression, opening a multi-billion-dollar market. Small position, asymmetric upside, but clinical trial risk remains the key factor.

Elake

StockTwits For Android 

COMPASS Pathways

 A high-risk, high-reward play on the future of mental health treatment. If its late-stage psilocybin therapy succeeds, the company could become a leader in treatment-resistant depression, opening a multi-billion-dollar market. Small position, asymmetric upside, but clinical trial risk remains the key factor.

Anon

@Borz92 in my mind there is no risk. It’s the way the planet is going. Canada just opened a bill to expand psychedelic therapy and USA signed an EO pushing the use of psychedelics for hard to treat mental health struggles. The only thing that stops this at this point is massive corruption. The writing is on the wall.

Tommaso Edoardo IV

Fitzgerald Davis

Josh

Jake

neil

StockTwits for iOS

 in my mind there is no risk. It’s the way the planet is going. Canada just opened a bill to expand psychedelic therapy and USA signed an EO pushing the use of psychedelics for hard to treat mental health struggles. The only thing that stops this at this point is massive corruption. The writing is on the wall.

Millionaire11

@Borz92 uneducated  low  iq  bot  comment

StockTwits Web

@Borz92 I think if anyone sees ”high risk” here they don&#39;t likely understand this company, clinical space,  or drug at all. 
 
Clinical trials for TRD are 100% complete. Thats it… There are not more trials to work through.

 I think if anyone sees ”high risk” here they don't likely understand this company, clinical space,  or drug at all. 
 
Clinical trials for TRD are 100% complete. Thats it… There are not more trials to work through.

Murphy Invests

@Borz92 What clinical trial risk? They just reported their last Phase 3 readout and solidly met all expectations with an NDA filing next. Tell me you know nothing about the company without saying you know nothing about the company.

 What clinical trial risk? They just reported their last Phase 3 readout and solidly met all expectations with an NDA filing next. Tell me you know nothing about the company without saying you know nothing about the company.

Ron S

My bad guys, was dealing with old info.

Its shifted from &quot;Will the drug work?&quot; to &quot;Will it be approved and successfully commercialized?&quot;. 

Risk: Still high. Clinical risk has been substantially reduced following two successful Phase 3 trials. The primary remaining risks are regulatory approval, commercialization, reimbursement, and execution.

 I know many of you really like this company, and I appreciate the corrections. I go based on the information I have at the time, and I&#39;m always happy to update my view when new facts come to light. I also follow hundreds of stock, not just one, so I&#39;ll occasionally miss an update. Cut me a little slack. 😄

My bad guys, was dealing with old info.

Its shifted from "Will the drug work?" to "Will it be approved and successfully commercialized?". 

Risk: Still high. Clinical risk has been substantially reduced following two successful Phase 3 trials. The primary remaining risks are regulatory approval, commercialization, reimbursement, and execution.

 I know many of you really like this company, and I appreciate the corrections. I go based on the information I have at the time, and I'm always happy to update my view when new facts come to light. I also follow hundreds of stock, not just one, so I'll occasionally miss an update. Cut me a little slack. 😄